Novo Nordisk maintains booming sales of obesity and diabetes drugs
- Posted on November 6, 2024
- By Financial Times
- 1 Views
Novo Nordisk maintains booming sales of obesity and diabetes drugs
Maker of blockbuster Wegovy and Ozempic treatments reports 21% rise in third-quarter sales
